Found: 18
Select item for more details and to access through your institution.
Drug-Drug Interaction of Omeprazole With the HCV Direct-Acting Antiviral Agents Paritaprevir/Ritonavir and Ombitasvir With and Without Dasabuvir.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 4, p. 269, doi. 10.1002/cpdd.246
- By:
- Publication type:
- Article
Efficacy and safety of ombitasvir/paritaprevir/ritonavir and dasabuvir with low‐dose ribavirin in patients with chronic hepatitis C virus genotype 1a infection without cirrhosis.
- Published in:
- Journal of Viral Hepatitis, 2019, v. 26, n. 8, p. 1027, doi. 10.1111/jvh.13109
- By:
- Publication type:
- Article
Assessment of Clinical Drug‐Drug Interactions of Elagolix, a Gonadotropin‐Releasing Hormone Receptor Antagonist.
- Published in:
- Journal of Clinical Pharmacology, 2020, v. 60, n. 12, p. 1606, doi. 10.1002/jcph.1689
- By:
- Publication type:
- Article
Population pharmacokinetics of paritaprevir, ombitasvir, dasabuvir, ritonavir and ribavirin in hepatitis C virus genotype 1 infection: analysis of six phase III trials.
- Published in:
- British Journal of Clinical Pharmacology, 2017, v. 83, n. 3, p. 527, doi. 10.1111/bcp.13138
- By:
- Publication type:
- Article
Clinical Pharmacology of Elagolix: An Oral Gonadotropin-Releasing Hormone Receptor Antagonist for Endometriosis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Population Pharmacokinetics of Elagolix in Healthy Women and Women with Endometriosis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Clinical Pharmacokinetics of Paritaprevir.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Population Pharmacokinetics of Paritaprevir, Ombitasvir, and Ritonavir in Japanese Patients with Hepatitis C Virus Genotype 1b Infection.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Dose- and Formulation-Dependent Non-Linear Pharmacokinetic Model of Paritaprevir, a Protease Inhibitor for the Treatment of Hepatitis C Virus Infection: Combined Analysis from 12 Phase I Studies.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Drug-Drug Interactions Between the Anti-Hepatitis C Virus 3D Regimen of Ombitasvir, Paritaprevir/Ritonavir, and Dasabuvir and Eight Commonly Used Medications in Healthy Volunteers.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Dosing Recommendations for Concomitant Medications During 3D Anti-HCV Therapy.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Exposure–Response Relationships for Efficacy and Safety of Risankizumab in Phase II and III Trials in Psoriasis Patients.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 2, p. 378, doi. 10.1002/cpt.1594
- By:
- Publication type:
- Article
Pharmacokinetics and immunogenicity of eftozanermin alfa in subjects with previously-treated solid tumors or hematologic malignancies: results from a phase 1 first-in-human study.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2024, v. 93, n. 4, p. 329, doi. 10.1007/s00280-023-04613-9
- By:
- Publication type:
- Article
Exposure‐Safety Analyses Identify Predictors of Change in Bone Mineral Density and Support Elagolix Labeling for Endometriosis‐Associated Pain.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2020, v. 9, n. 11, p. 639, doi. 10.1002/psp4.12560
- By:
- Publication type:
- Article
Effect of Elagolix Exposure on Clinical Efficacy End Points in Phase III Trials in Women With Endometriosis‐Associated Pain: An Application of Markov Model.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2020, v. 9, n. 8, p. 466, doi. 10.1002/psp4.12545
- By:
- Publication type:
- Article
Steady-state pharmacokinetics and bioavailability of immediate-release and extended-release formulations of lamotrigine in elderly epilepsy patients: Use of stable isotope methodology.
- Published in:
- Journal of Clinical Pharmacology, 2015, v. 55, n. 10, p. 1101, doi. 10.1002/jcph.522
- By:
- Publication type:
- Article
Lamotrigine pharmacokinetics following oral and stable‐labeled intravenous administration in young and elderly adult epilepsy patients: Effect of age.
- Published in:
- Epilepsia (Series 4), 2018, v. 59, n. 9, p. 1718, doi. 10.1111/epi.14519
- By:
- Publication type:
- Article
Validation of a quantitative systems pharmacology model of calcium homeostasis using elagolix Phase 3 clinical trial data in women with endometriosis.
- Published in:
- CTS: Clinical & Translational Science, 2021, v. 14, n. 4, p. 1611, doi. 10.1111/cts.13040
- By:
- Publication type:
- Article